Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Neoplasms, Castration-Resistant

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, S1
Chen, T1
Yu, X1
Luo, M1
Chen, X1
Lin, C1
Lai, Y1
Huang, H1
Kosaka, T1
Miyajima, A1
Shirotake, S1
Kikuchi, E1
Oya, M1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Neoplasms, Castration-Resistant

ArticleYear
The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
    Oncology reports, 2017, Volume: 37, Issue:5

    Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell

2017
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
    The Prostate, 2011, Oct-01, Volume: 71, Issue:14

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Proteins; Cell Line, Tumor; Chromones; Enzym

2011